In Case You Missed It: The First CRISPR Clinical Trial, A New Shield for Chernobyl—and More! – Scientific American
|
In Case You Missed It: The First CRISPR Clinical Trial, A New Shield for Chernobyl—and More!
Scientific American The first clinical trial to employ cells edited by the genetic tool CRISPR/Cas9 is now under way in China. Three more are scheduled to begin next month. In all four, humans are injected with modified immune cells that researchers hope will fight … |
